Sander van Hooff

20062024

Research activity per year

Network

Joyce Buikhuisen

Person: Academic

Eline Soer

Person: Academic

R. Volckmann

Person: Academic

Kaylee M. Keller

  • Princess Maxima Center for Pediatric Oncology, 3584 CS, Utrecht, The Netherlands
  • Princess Máxima Center for Pediatric Oncology

External person

Linda G. Schild

  • Princess Máxima Center for Pediatric Oncology

External person

Karin P. S. Langenberg

  • Princess Maxima Center of Pediatric Oncology, 3584, Netherlands

External person

Kimberley Ober

  • Princess Maxima Center for Pediatric Oncology, 3584 CS, Utrecht, The Netherlands

External person

Ronald de Krijger

  • Princess Maxima Center for Pediatric Oncology, 3584 CS, Utrecht, The Netherlands
  • University Medical Centre Utrecht

External person

Marlinde L. van den Boogaard

  • Princess Maxima Center for Pediatric Oncology, 3584 CS, Utrecht, The Netherlands
  • Princess Máxima Center for Pediatric Oncology

External person

Selma Eising

  • Princess Máxima Center for Pediatric Oncology

External person

Annelisa M. Cornel

  • University Medical Centre Utrecht
  • Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Utrecht University

External person

Hans Clevers

  • Royal Netherlands Academy of Arts and Sciences

External person

Vicky Amo-Addae

  • Princess Máxima Center for Pediatric Oncology

External person

Marijn Scheijde-Vermeulen

  • Princess Maxima Center for Pediatric Oncology, 3584 CS, Utrecht, The Netherlands

External person

Karin Straathof

  • University College London
  • NIHR Great Ormond Street Biomedical Research Centre, London, UK

External person

M. H. Wijnen

  • Dutch Childhood Oncology Group (DCOG), Princess Máxima Centre, Utrecht, The Netherlands

External person

Daniëlle Dekker

  • University of Amsterdam
  • Oncode Institute, 3521 AL, Utrecht, The Netherlands

External person

Josephine G. M. Strijker

  • Princess Maxima Center for Pediatric Oncology, 3584 CS, Utrecht, The Netherlands

External person

Sam Behjati

  • Wellcome Sanger Institute
  • University of Cambridge

External person

Jarno Drost

  • Netherlands Cancer Institute

External person

Kim van den Handel

  • Princess Máxima Center for Pediatric Oncology

External person

D. F. Vincent

  • University of Glasgow

External person

Melania Lo Iacono

  • University of Palermo

External person

Uri Ilan

  • Princess Máxima Center for Pediatric Oncology

External person

Anne L. Borst

  • Princess Máxima Center for Pediatric Oncology

External person

Esther Hulleman

  • Vrije Universiteit Amsterdam

External person

Marco Marzano

  • University of Amsterdam

External person

Rick Kaplan

  • University College London

External person

Ignacio del Valle

  • University College London

External person

Dilara Ayyildiz

  • Princess Maxima Center of Pediatric Oncology, 3584, Netherlands
  • Oncode Institute, Heidelberglaan 25, 3584 Utrecht, the Netherlands

External person

Loes A. M. Meijs

  • Princess Máxima Center for Pediatric Oncology

External person

Gerda Kildisiute

  • Wellcome Sanger Institute

External person

Jasper van der Lugt

  • University of Amsterdam

External person

Sara Vitale

  • Catholic University of the Sacred Heart
  • Istituto Superiore di Sanita

External person

Ester G. Vázquez

  • University of Oxford

External person

William J. Faller

  • Netherlands Cancer Institute

External person

Cecilia de Heus

  • University Medical Centre Utrecht
  • Amsterdam UMC

External person

Irene Pillitteri

  • University of Palermo

External person

Mariëtte E. G. Kranendonk

  • University Medical Centre Utrecht
  • Princess Maxima Center for Pediatric Oncology, 3584 CS, Utrecht, The Netherlands

External person

Simone Punt

  • Universiteit Leiden: department of Pathology.

External person

Xin Wang

  • University Medical Center Utrecht
  • University of Toledo
  • 23andMe Inc.
  • City University of Hong Kong

External person

Jessica Pritchard

  • University of Amsterdam
  • Oncode Institute, Amsterdam, the Netherlands

External person

Lennart A. Kester

  • Princess Máxima Center for Pediatric Oncology

External person

Dustin J. Flanagan

  • University of Glasgow

External person

Shenglin Mei

  • Harvard University

External person

Nikola Vlahov

  • University of Glasgow

External person

Wei Wu

  • South China University of Technology
  • Stanford University
  • Department of Veterans Affairs

External person

Asier Unciti-Broceta

  • University of Edinburgh

External person

Omer Bayraktar

  • Wellcome Sanger Institute

External person

Ronja Pscheid

  • Gadeta B.V., 3584 CM, Utrecht, The Netherlands

External person

Nathalie Sphyris

  • University of Glasgow

External person

Michael R. van Gerven

  • Princess Maxima Center for Pediatric Oncology, 3584 CS, Utrecht, The Netherlands

External person

Federica Martorana

  • University of Catania

External person

Eva Bugallo-Blanco

  • University College London

External person

Peter Bailey

  • University of Glasgow

External person

Diego di Bernardo

  • Fondazione Telethon
  • University of Naples “Federico II”

External person

Nick S. Macklon

  • University of Southampton
  • Sjællands Universitetshospital

External person

Christine Thevanesan

  • University College London

External person

Xiaochen Long

  • Texas Children's Hospital Houston
  • Rice University

External person

Barbara C. Jones

  • German Cancer Research Center
  • Heidelberg University

External person

N. Lansu

  • University Medical Centre Utrecht

External person

Femke van den Ham

  • National Institute of Public Health and the Environment

External person

Mark Hughes

  • University of Glasgow

External person

Gerrit K J Hooijer

  • University of Amsterdam
  • Amsterdam University Medical Centers

External person

Giorgio Giannone

  • Department of Experimental Oncology, Mediterranean Institute of Oncology, Viagrande, Catania, Italy

External person

Louise Brown

  • University College London

External person

Restuadi Restuadi

  • University of Queensland

External person

Courtney Himsworth

  • University College London

External person

Vincenzo Luca Lentini

  • General Surgery Department, Azienda Ospedaliera, Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy

External person

D. Strathdee

  • University of Glasgow

External person

Paolo Vigneri

  • University of Catania

External person

Bianca F. Goemans

  • Princess Maxima Center for Pediatric Oncology, 3584 CS, Utrecht, The Netherlands
  • Vrije Universiteit Amsterdam

External person

Luuk A. Broeils

  • Princess Máxima Center for Pediatric Oncology

External person

Arafath K. Najumudeen

  • University of Glasgow

External person

Viktor Koelzer

  • University of Bern

External person

Ian Tomlinson

  • University of Oxford

External person

Mirjam Blattner-Johnson

  • Hopp Children’s Cancer Center (KiTZ), Heidelberg, Germany
  • German Cancer Research Center

External person

Joost Koetsier

  • Princess Máxima Center for Pediatric Oncology

External person

Lorenzo Colarossi

  • Department of Experimental Oncology, Mediterranean Institute of Oncology, Viagrande, Catania, Italy

External person

Stefan Nierkens

  • Utrecht University

External person

Petros Tsantoulis

  • University of Geneva

External person

Lan Zhao

  • City University of Hong Kong

External person

Veronica Veschi

  • University of Palermo

External person

Peter J. Campbell

  • Wellcome Sanger Institute
  • University of Cambridge
  • Cambridge University Hospitals NHS Foundation Trust

External person

Chris Coomans

  • Gadeta B.V., 3584 CM, Utrecht, The Netherlands

External person

Miriam Stumpf

  • Princess Máxima Center for Pediatric Oncology

External person

Maria Rita Bongiorno

  • University of Palermo

External person

Ninib Baryawno

  • Karolinska Institutet

External person

Juliet C. Gray

  • University of Southampton

External person

Gareth J. Inman

  • University of Glasgow

External person

Alexander Raven

  • University of Glasgow

External person

Jayne Y. Hehir-Kwa

  • Radboud University Nijmegen
  • Princess Máxima Center for Pediatric Oncology

External person

Dan Luedtke

  • Eli Lilly

External person

Hua-Sheng Chiu

  • Baylor College of Medicine

External person

Marta Barisa

  • University College London

External person

Monique L. den Boer

  • Erasmus Universiteit Rotterdam

External person

Manuel Salto-Tellez

  • Queen's University Belfast

External person

Emanuele Martorana

  • IOM (Mediterranean Institute of Oncology) Ricerca, Viagrande, Catania, Italy

External person

Catriona Duncan

  • NIHR Great Ormond Street Biomedical Research Centre, London, UK

External person

Jessica J. F. van der Hoek

  • Princess Maxima Center for Pediatric Oncology, 3584 CS, Utrecht, The Netherlands

External person

Bronte M. Verhoeven

  • Karolinska Institutet

External person

Alvaro Sanchez-Bernabeu

  • Utrecht University

External person

Amira Kramdi

  • Institut Curie

External person

Gianmarco Motta

  • University of Catania

External person

Tim Maughan

  • University of Oxford

External person

Nil A. Schubert

  • Princess Máxima Center for Pediatric Oncology

External person

Micol Eleonora Fiori

  • Istituto Superiore di Sanita

External person

Clarissa N. Pacyna

  • Wellcome Sanger Institute

External person

Mohammad Javad Najaf Panah

  • Texas Children's Hospital Houston

External person

Michael T. Meister

  • Princess Máxima Center for Pediatric Oncology
  • Oncode Institute, Heidelberglaan 25, 3584 Utrecht, the Netherlands

External person

Selina Jansky

  • Hopp Children’s Cancer Center Heidelberg (KiTZ), Heidelberg, Germany
  • German Cancer Research Center

External person

Pavel Sumazin

  • Cancer Research Institute Ghent (CRIG), Ghent, Belgium

External person

Andrea Bisso

  • Gadeta B.V., 3584 CM, Utrecht, The Netherlands

External person

Sophie Munnings-Tomes

  • University College London

External person

Joshua Hordern

  • University of Oxford

External person

Marinus J. C. Eijkemans

  • Utrecht University

External person

Xiaoling He

  • University of Cambridge

External person

Dario Giuffrida

  • Department of Experimental Oncology, Mediterranean Institute of Oncology, Viagrande, Catania, Italy

External person

John C. Achermann

  • University College London

External person

Freerk van Dijk

  • University of Groningen

External person

Philip Dunne

  • Queen's University Belfast

External person

Patricia M. Gomez Barila

  • University of Amsterdam
  • Oncode Institute, 3521 AL, Utrecht, The Netherlands

External person

S. K. Fey

  • University of Glasgow

External person

Pieter Wesseling

  • Vrije Universiteit Amsterdam
  • 2-BBB Medicines
  • Radboud University Nijmegen
  • Amsterdam UMC

External person

Francesca Buffa

  • University of Oxford

External person

Kenny Roberts

  • Wellcome Sanger Institute

External person

Rob Pieters

  • Princess Máxima Center for Pediatric Oncology

External person

Rasa Elmentaite

  • Wellcome Sanger Institute

External person

Apurva Gopisetty

  • Hopp Children’s Cancer Center (KiTZ), Heidelberg, Germany
  • German Cancer Research Center

External person

Christina Burke

  • University College London

External person

Gnana P. Balasubramanian

  • German Cancer Research Center

External person

Alice Piapi

  • University College London

External person

Leendert Looijenga

  • Princess Máxima Center for Pediatric Oncology

External person

Eleonora Khabirova

  • Wellcome Sanger Institute

External person

Francisca J. Bergsma

  • Princess Máxima Center for Pediatric Oncology

External person

Barry J. Thompson

  • Australian National University

External person

Judith M. Boer

  • Leiden University
  • Erasmus Universiteit Rotterdam
  • Netherlands Bioinformatics Center

External person

Tamsin R. M. Lannagan

  • University of Glasgow

External person

Chris C. Holmes

  • University of Oxford

External person

Elisa Zappa

  • Princess Máxima Center for Pediatric Oncology

External person

Lieke Welling

  • Amsterdam University Medical Centers
  • Vrije Universiteit Amsterdam
  • University of Amsterdam
  • Leiden University

External person

Francisco Avila Cobos

  • Ghent University
  • Cancer Research Institute Ghent (CRIG)

External person

Marzia Mare

  • Department of Experimental Oncology, Mediterranean Institute of Oncology, Viagrande, Catania, Italy
  • University of Messina

External person

Irene Paassen

  • Princess Maxima Center of Pediatric Oncology, 3584, Netherlands
  • Oncode Institute, Heidelberglaan 25, 3584 Utrecht, the Netherlands

External person

Davide Stefano Sardina

  • University of Palermo

External person

Anke Essing

  • Princess Máxima Center for Pediatric Oncology

External person

Paola Bianca

  • University of Palermo

External person

Eleonora J. Looze

  • Princess Máxima Center for Pediatric Oncology

External person

Annalisa Nicotra

  • University of Palermo

External person

Michele L. Redell

  • Texas Children's Hospital Houston

External person

A. Beggs

  • University of Birmingham

External person

Jessica Epps

  • Texas Children's Hospital Houston

External person

J. J. Bakhuizen

  • Princess Máxima Center for Pediatric Oncology
  • Utrecht University

External person

Johanna A. Tol

  • Erasmus Universiteit Rotterdam
  • University of Amsterdam
  • Amsterdam University Medical Centers

External person

Michael J. Krueger

  • Texas Children's Hospital Houston

External person

H. Josef Vormoor

  • Princess Máxima Center for Pediatric Oncology
  • University of Zurich
  • Newcastle University

External person

Elizabeth Calton

  • Oncogenetics Team, The Institute of Cancer Research, London, United Kingdom

External person

Arjan Boltjes

  • University Medical Centre Utrecht

External person

K. Gilroy

  • University of Glasgow

External person

Romy van Oosterhout

  • Princess Máxima Center for Pediatric Oncology

External person